This new oral medication from Eli Lilly, which also comes with no food or drink restrictions, could change that
For patients I see in clinic, retatrutide may potentially be a highly impactful future tool to treat their obesity and transform their health trajectory. Commenting on the topline results, Professor Graham Finlayson, chair in psychobiology at the University of Leeds, said it was striking to see retatrutide reaching the weight loss range historically associated with bariatric surgery and that the headline efficacy results are impressive, particularly the proportion of participants reported to achieve very large weight losses. He added: In principle, that broader pharmacology could produce larger effects on body weight and metabolism, although the full peer-reviewed data will be needed to understand the balance between efficacy, tolerability and discontinuation. While this clinical trial did not examine weight regain after stopping retatrutide, other studies have found that discontinuing weight-loss medications such as semaglutide and liraglutide typically results in near-total weight regain within about 18 months
When adipose tissue lets you down: understanding the functions of genes disrupted in lipodystrophy
Ongoing care and dose adjustments are determined by your supervising provider
Role of the gut microbiota in inflammatory bowel disease pathogenesis: what have we learnt in the past 10 years
Research Peptide Considerations Research peptide suppliers: Companies like Red Fox Peptides provide third-party HPLC/MS testing, 98%+ purity verification, with delivery within 2-4 days for Canadian customers Verify third-party testing
